Kenya's ARV drug use overtakes Uganda's

1 October 2006

Figures showing the numbers of HIV positive patients in African countries who are receiving antiretroviral drug treatments reveal that Kenya's patient numbers receiving treatment could soon overtake Uganda's totals.

Last December, more than 70,000 people in Kenya were on ARV drugs, compared with Uganda's 79,000. An estimated 273,000 people in the former country require treatment versus 148,000 in Uganda, which has the highest proportion (53%) of treated HIV/AIDS patients among African nations.

With the improvements in treatment rates have come major falls in the prevalence of the disease: both Kenya and Uganda have seen infection rates fall from nearly 20% in the mid-1990s to under 7% at present.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight